The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1

Smad-dependent and Smad-independent pathways in TGF-β family signalling

Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498

Liver fibrosis

Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958

Mechanisms of hepatic stellate cell activation

Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909

Smad transcription factorsPreprint

Massagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,519

Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method

Rahman, I., Kode, A., & Biswas, S. K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.378 · Cited by 2,325

Liver fibrosis and repair: Immune regulation of wound healing in a solid organ

Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310

SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor

Tsukazaki, T., Chiang, T., Davison, A. F., Attisano, L., & Wrana, J. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81701-8 · Cited by 981

Oxidative stress-related molecules and liver fibrosis

Parola, M., & Robino, G. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00142-8 · Cited by 781

Protocol for the fast chromatin immunoprecipitation (ChIP) method

Nelson, J. D., Denisenko, O. N., & Bomsztyk, K. (2006) · Nature Protocols · doi:10.1038/nprot.2006.27 · Cited by 772

High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers

Mederacke, I., Dapito, D. H., Affò, S., Uchinami, H., & Schwabe, R. F. (2015) · Nature Protocols · doi:10.1038/nprot.2015.017 · Cited by 548

Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers

Forman, H. J., Fukuto, J. M., & Torrès, M. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00516.2003 · Cited by 533

Molecular Mechanisms and Clinical Implications of Reversible Protein S -Glutathionylation

Mieyal, J. J., Gallogly, M. M., Qanungo, S., Sabens, E. A., & Shelton, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2089 · Cited by 523

lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer

Wang, Z., Yang, B., Zhang, M., Guo, W., Wu, Z., Wang, Y., Jia, L., Li, S., Johnson, R., Demchok, J. A., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.006 · Cited by 473

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent

Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336

Transsulfuration Activity Can Support Cell Growth upon Extracellular Cysteine Limitation

Zhu, J., Berisa, M., Schwörer, S., Qin, W., Cross, J. R., & Thompson, C. B. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.09.009 · Cited by 292

p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer

Durán, Á., Hernandez, E. D., Reina‐Campos, M., Castilla, E. A., Subramaniam, S., Raghunandan, S., Roberts, L. R., Kisseleva, T., Karin, M., Díaz-Meco, M. T., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.004 · Cited by 243

Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1

Song, J. J., & Lee, Y. J. (2003) · Biochemical Journal · doi:10.1042/bj20030275 · Cited by 183

Protein-Thiol Oxidation and Cell Death: Regulatory Role of Glutaredoxins

Allen, E. M. G., & Mieyal, J. J. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4644 · Cited by 172

The multifaceted role of pirfenidone and its novel targets

Macías‐Barragán, J., Sandoval-Rodriguez, A. S., Navarro‐Partida, J., & Armendáriz‐Borunda, J. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-16 · Cited by 165

Discovery of Chromone‐Based Inhibitors of the Transcription Factor STAT5

Müller, J., Sperl, B., Reindl, W., Kiessling, A., & Berg, T. (2008) · ChemBioChem · doi:10.1002/cbic.200700701 · Cited by 151

Redox Regulation via Glutaredoxin-1 and Protein S -Glutathionylation

Matsui, R., Ferrán, B., Oh, A., Croteau, D., Shao, D., Han, J., Pimentel, D. R., & Bachschmid, M. M. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7963 · Cited by 142

Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production

Di Sario, A., Bendia, E., Svegliati Baroni, G., Ridolfi, F., Casini, A., Ceni, E., Saccomanno, S., Marzioni, M., Trozzi, L., Sterpetti, P., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00245-3 · Cited by 138

Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy

Hu, M., Wang, Y., Xu, L., An, S., Tang, Y., Zhou, X., Li, J., Liu, R., & Huang, L. (2019) · Nature Communications · doi:10.1038/s41467-019-10893-8 · Cited by 131

Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells

Novo, E., Busletta, C., di Bonzo, L. V., Povero, D., Paternostro, C., Mareschi, K., Ferrero, I., David, E., Bertolani, C., Caligiuri, A., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.09.022 · Cited by 129

Reducing protein oxidation reverses lung fibrosis

Anathy, V., Lahue, K. G., Chapman, D. G., Chia, S. B., Casey, D. T., Aboushousha, R., van der Velden, J. L. J., Elko, E. A., Hoffman, S. M., McMillan, D. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0090-y · Cited by 119

Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction

Diamond, D. L., Jacobs, J. M., Paeper, B., Proll, S. C., Gritsenko, M. A., Carithers, R. L., Larson, A. M., Yeh, M. M., Camp, D. G., Smith, R. D., et al. (2007) · Hepatology · doi:10.1002/hep.21751 · Cited by 114

Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice

Yan, J., Tung, H., Li, S., Niu, Y., Garbacz, W. G., Lu, P., Bi, Y., Li, Y., He, J., Xu, M., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.05.066 · Cited by 109

Potent antioxidant role of Pirfenidone in experimental cirrhosis

Salazar-Montes, A., Ruiz-Corro, L., López-Reyes, A. G., Castrejón-Gómez, E., & Armendáriz‐Borunda, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.110 · Cited by 99

Isolation of Kupffer Cells and Hepatocytes from a Single Mouse Liver

Aparicio-Vergara, M., Tencerová, M., Morgantini, C., Barreby, E., & Aouadi, M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7163-3_16 · Cited by 97

Purification of Hepatocytes and Sinusoidal Endothelial Cells from Mouse Liver Perfusion

Cabral, F., Miller, C. M., Kudrna, K. M., Hass, B. E., Daubendiek, J. G., Kellar, B. M., & Harris, E. N. (2018) · Journal of Visualized Experiments · doi:10.3791/56993 · Cited by 84

Pirfenidone Inhibits Dimethylnitrosamine‐Induced Hepatic Fibrosis In Rats

Tada, S., Nakamuta, M., Enjoji, M., Sugimoto, R., Iwamoto, H., Kato, M., Nakashima, Y., & Nawata, H. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03481.x · Cited by 79

Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis

Komiya, C., Tanaka, M., Tsuchiya, K., Shimazu, N., Mori, K., Furuke, S., Miyachi, Y., Shiba, K., Yamaguchi, S., Ikeda, K., et al. (2017) · Scientific Reports · doi:10.1038/srep44754 · Cited by 65

The role of redox mechanisms in hepatic chronic wound healing and fibrogenesis

Novo, E., & Parola, M. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s4 · Cited by 63

Pirfenidone inhibits carbon tetrachloride‐ and albumin complex‐induced liver fibrosis in rodents by preventing activation of hepatic stellate cells

Zhao, X., Zeng, X., Li, X., Wang, T., & Wang, B.-E. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05194.x · Cited by 53

Advanced Method for Isolation of Mouse Hepatocytes, Liver Sinusoidal Endothelial Cells, and Kupffer Cells

Liu, J., Huang, X., Werner, M., Broering, R., Yang, D., & Lu, M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6700-1_21 · Cited by 52

Genome-wide analyses reveal the extent of opportunistic STAT5 binding that does not yield transcriptional activation of neighboring genes

Zhu, B., Kang, K., Yu, J. H., Chen, W., Smith, H. E., Lee, D., Sun, H., Wei, L., & Hennighausen, L. G. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks056 · Cited by 45

Novel drug targets for idiopathic pulmonary fibrosis

Sgalla, G., Cocconcelli, E., Tonelli, R., & Richeldi, L. (2016) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2016.1152186 · Cited by 43

Nanoparticle‐mediated HMGA1 Silencing Promotes Lymphocyte Infiltration and Boosts Checkpoint Blockade Immunotherapy for Cancer

Wang, Y., Song, W., Hu, M., An, S., Xu, L., Li, J., Kinghorn, K., Liu, R., & Huang, L. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201802847 · Cited by 42

Regulation of apoptosis through cysteine oxidation: implications for fibrotic lung disease

Janssen-Heininger, Y. M. W., Aesif, S. W., van der Velden, J. L. J., Guala, A. S., Reiss, J. N., Roberson, E. C., Budd, R. C., Reynaert, N. L., & Anathy, V. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05553.x · Cited by 33

Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA

Chedid, M. F. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4724-6 · Cited by 30

Cigarette Smoke Targets Glutaredoxin 1, Increasing S-Glutathionylation and Epithelial Cell Death

Kuipers, I., Guala, A. S., Aesif, S. W., Konings, G. F. J., Bouwman, F. G., Mariman, E. C. M., Wouters, E. F. �., Janssen-Heininger, Y. M. W., & Reynaert, N. L. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0249oc · Cited by 29

Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis

Hu, M., Zhou, X., Wang, Y., Guan, K., & Huang, L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.12.053 · Cited by 28

Repurposing Pirfenidone for Nonalcoholic Steatohepatitis-related Cirrhosis: A Case Series

Philips, C. A., Padsalgi, G., Ahamed, R., Paramaguru, R., Rajesh, S. K., George, T., Mahadevan, P., & Augustine, P. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2019.00056 · Cited by 10

Hepatic steroid sulfatase critically determines estrogenic activities of conjugated equine estrogens in human cells in vitro and in mice

Feng, Y., Xie, Y., Xu, M., Li, L., Selcer, K. W., Oberly, P. J., Poloyac, S. M., Wang, H., Li, C., Dong, F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009181 · Cited by 6

Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies

Lurje, I., Gaisa, N. T., Weiskirchen, R., & Tacke, F. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101191 · Cited by 152

Investigating the possible mechanisms of pirfenidone to be targeted as a promising anti-inflammatory, anti-fibrotic, anti-oxidant, anti-apoptotic, anti-tumor, and/or anti-SARS-CoV-2

Antar, S. A., Saleh, M. A., & Al-Karmalawy, A. A. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121048 · Cited by 73

Activation of Sirtuin3 by honokiol ameliorates alveolar epithelial cell senescence in experimental silicosis via the cGAS-STING pathway

Zhou, Q., Yi, G., Chang, M., Li, N., Bai, Y., Li, H., & Yao, S. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103224 · Cited by 57

Targeting HSP47 and HSP70: promising therapeutic approaches in liver fibrosis management

El-Fattah, E. E. A., & Zakaria, A. Y. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03759-z · Cited by 43

Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse

Amargant, F., Magalhaes, C., Pritchard, M. T., & Duncan, F. E. (2024) · GeroScience · doi:10.1007/s11357-024-01322-w · Cited by 41

Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies

Chen, X., Zhang, J., Guo, L., Wu, C., Zhou, J., Xu, M., Mo, L., Li, Y., & He, J. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02532-0 · Cited by 40

Liver cirrhosis: molecular mechanisms and therapeutic interventions

Dong, Z., Wang, Y., & Jin, W. (2024) · MedComm · doi:10.1002/mco2.721 · Cited by 32

Small-molecule natural plants for reversing liver fibrosis based on modulation of hepatic stellate cells activation: An update

Zheng, Y., Xie, L., Yang, D., Luo, K., & Li, X. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154721 · Cited by 32

XIAP-mediated degradation of IFT88 disrupts HSC cilia to stimulate HSC activation and liver fibrosis

Hong, R., Tan, Y., Tian, X., Huang, Z., Wang, J., Ni, H., Yang, J. N., Bu, W., Yang, S., Li, T., et al. (2024) · EMBO Reports · doi:10.1038/s44319-024-00092-y · Cited by 29

Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone

Ma, H., Heiden, J. A. V., Uttarwar, S., Xi, Y., N’Diaye, E.-N., LaCanna, R., Caplazi, P., Gierke, S., Moffat, J. G., Wolters, P. J., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00604-2022 · Cited by 28

Comprehensive Review of the Vascular Niche in Regulating Organ Regeneration and Fibrosis

Chen, Y., & Ding, B. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac070 · Cited by 26

Chemistry and biology of enzymes in protein glutathionylation

Oppong, D., Schiff, W., Shivamadhu, M. C., & Ahn, Y. (2023) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2023.102326 · Cited by 24

Caveolin-1-Related Intervention for Fibrotic Lung Diseases

Shetty, S., & Idell, S. (2023) · Cells · doi:10.3390/cells12040554 · Cited by 20

Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation

Xia, Y., Xu, Y., Liu, Q., Zhang, J., Zhang, Z., Jia, Q., Tang, Q., Jing, X., Li, J., Chen, J.-H., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155610 · Cited by 20

The Role of S-Glutathionylation in Health and Disease: A Bird’s Eye View

Federici, L., Masulli, M., Laurenzi, V. D., & Allocati, N. (2024) · Nutrients · doi:10.3390/nu16162753 · Cited by 20

Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy

Wang, K., Chen, H. H., Qin, S., Chen, S., Zhang, Q. Y., Chen, J., Di, D., Su, G., & Yuan, Y. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113567 · Cited by 19

Sulfation of chondroitin and bile acids converges to antagonize Wnt/β-catenin signaling and inhibit APC deficiency-induced gut tumorigenesis

Xu, P., Xi, Y., Kim, J., Zhu, J., Zhang, M., Xu, M., Ren, S., Yang, D., Ma, X., & Xie, W. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.006 · Cited by 19

Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose

Tung, H., Kim, J.-W., Zhu, J., Li, S., Yan, J., Liu, Q., Koo, I., Кошкин, С. А., Hao, F., Zhong, G. G., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adk8446 · Cited by 19

Hydrogel microneedle patch for treatment of liver fibrosis

Gu, X., Wu, Z., Wu, D., Hou, B., Bian, L., Zhou, T., Hou, Y., Wang, H., & Zheng, Z. (2023) · Materials Today Advances · doi:10.1016/j.mtadv.2023.100417 · Cited by 18

Glutaredoxin-1 alleviates acetaminophen-induced liver injury by decreasing its toxic metabolites

Xu, Y. X., Xia, Y., Liu, Q., Jing, X., Tang, Q., Zhang, J., Jia, Q., Zhang, Z., Li, J., Chen, J.-H., et al. (2023) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2023.08.004 · Cited by 17

Ciliary and Non-Ciliary Roles of IFT88 in Development and Diseases

Wang, X., Yin, G., Yang, Y., & Tian, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052110 · Cited by 16

Pirfenidone alleviates fibrosis by acting on tumour–stroma interplay in pancreatic cancer

Lei, Y., Xu, J., Xiao, M., Wu, D., Xu, H., Yang, J., Mao, X., Pan, H., Yu, X., & Shi, S. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02631-9 · Cited by 15

Glutaredoxin‐1 promotes lymphangioleiomyomatosis progression through inhibiting Bim‐mediated apoptosis via COX2/PGE2/ERK pathway

Feng, Y., Li, T., Li, Y., Lin, Z., Han, X., Pei, X., Zhang, Y., Li, F., Yang, J., Shao, D., et al. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1333 · Cited by 12

The desulfinylation enzyme sulfiredoxin-1 attenuates HSC activation and liver fibrosis by modulating the PTPN12-NLRP3 axis

Kim, J.-W., Tung, H., Ke, M., Xu, P., Cai, X., Xi, Y., Xu, M., Ren, S., Huang, Y., Bhowmik, A., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000001133 · Cited by 12

Integrated bioinformatics analysis identifies established and novel TGFβ1-regulated genes modulated by anti-fibrotic drugs

Wilson, A. C., Chiles, J. W., Ashish, S. Y., Chanda, D., Kumar, P. L., Mobley, J. A., Neptune, E., Thannickal, V. J., & McDonald, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-07151-1 · Cited by 12

Lactoferrin as a therapeutic agent for attenuating hepatic stellate cell activation in thioacetamide-induced liver fibrosis

Pu, T.-Y., Chuang, K.-C., Tung, M., Yen, C., Chen, Y., Cidem, A., Ko, C.-H., Chen, W., & Chen, C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116490 · Cited by 11

A loss-of-function human ADAR variant activates innate immune response and promotes bowel inflammation

Xu, P., Xi, Y., Kim, J., Zhang, M., Gao, C., Wang, Y., Xu, M., Wang, X. T., Ren, S., Yang, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63554-4 · Cited by 10

Stromal Reprogramming Optimizes KRAS-Specific Chemotherapy Inducing Antitumor Immunity in Pancreatic Cancer

Hu, Q., Feng, J., Qi, L., & Jin, Y. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c10404 · Cited by 9

RYK is a GPNMB receptor that drives MASH

Xi, Y., Zeng, W., Luo, J., Zhou, J., Wang, L., Sun, J., He, Z., Li, W., Zhu, S., Qi, W., et al. (2026) · Nature · doi:10.1038/s41586-026-10160-z · Cited by 9

Oral delivery of ferroptosis inducers for effective treatment of hepatic fibrosis

Yu, Y., Zhang, S., Xu, Y., Shao, H., & Luo, L. (2024) · Nano Research · doi:10.1007/s12274-024-6725-z · Cited by 9

Boiling histotripsy exhibits anti-fibrotic effects in animal models of liver fibrosis

Joung, C., Heo, J., Pahk, K. J., & Pahk, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-66078-x · Cited by 9

H3K9me3 demethylation by JMJD2B is regulated by pirfenidone resulting in improved NASH

Rodríguez-Sanabria, J. S., Rosas-Campos, R., Vázquez-Esqueda, Á. O., Palacios‐Marin, I., Jiménez‐Chillarón, J. C., Escutia-Gutiérrez, R., Jave‐Suárez, L. F., Galicia‐Moreno, M., Monroy-Ramírez, H. C., Reyes, E. C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-75458-2 · Cited by 9

Amelioration of Liver Fibrosis via In Situ Hepatic Stellate Cell Conversion Through Co‐Inhibition of TGF ‐β and GSK ‐3 Signalling

Zhu, X., Zhong, Z., Du, J., Zhang, J., Zhang, X., Cui, X., Guan, L., Hu, Y., Chen, C., Wang, H., et al. (2025) · Liver International · doi:10.1111/liv.70187 · Cited by 8

Exploring Cirrhosis: Insights into Advances in Therapeutic Strategies

Wiącek, M., Adam, A., Studnicki, R., & Zubrzycki, I. Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157226 · Cited by 7

Combination of silybin and carvedilol synergistically alleviates liver fibrosis by inhibiting Wnt/β-catenin signaling

Chen, A., Zhu, X., Jiang, H., Gong, M., Cui, S., Wang, G., Wang, H., & Hao, H. (2025) · Targetome · doi:10.48130/targetome-0025-0009 · Cited by 7

Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axis

Yang, S., Zhang, R., Deng, W., Chang, S.-C., Li, Y., & Li, S. (2023) · Inflammation Research · doi:10.1007/s00011-023-01776-2 · Cited by 7

Synthesis and evaluation of new pirfenidone derivatives as anti-fibrosis agents

Gu, C., Li, W., Ju, Q., Yao, H., Yang, L., An, B., Hu, W., & Li, X. (2022) · RSC Advances · doi:10.1039/d2ra00990k · Cited by 7

Facile synthesis of multisubstituted 2,3-dihydrofurans via intermolecular cyclization of enals or alkyl/aryl aldehydes with acyl-stabilized sulfur ylides

Su, Y., Sun, Z., Zhao, Q., & Fu, L. (2025) · Chemical Communications · doi:10.1039/d5cc06219e · Cited by 6

Daidzein alleviates CCl 4 - and BDL-induced liver fibrosis via suppressing the integrin alphaVbeta1/YAP signaling

Bai, J., Yang, Z., Wang, P., Qian, B., Jiang, Z., Xu, T., Pu, H., Ye, M., Du, Y., & Fu, W. (2025) · Food & Function · doi:10.1039/d5fo01024a · Cited by 6

Pirfenidone Downregulates eIF6, P311, and TGF-β Expression and Improves Liver Fibrosis Induced by Bile Duct Ligation in Wistar Rats: Evidence for Liver Regeneration

Yousefi, Z., Nourbakhsh, M., & Lotfi, A. S. (2024) · DNA and Cell Biology · doi:10.1089/dna.2024.0194 · Cited by 5

Targeting ADAR1-mediated RNA editing inhibits hepatic stellate cell activation and liver fibrosis by enhancing HSC-intrinsic innate immunity

Xi, Y., Liu, L., Kim, J.-W., Zhang, M., Wang, X., Abdirassil, A., Xu, M., Ren, S., Wang, Q., Yang, D., et al. (2026) · Gut · doi:10.1136/gutjnl-2025-335942 · Cited by 5

The anti-liver fibrosis effect of Tibetan medicine (Qiwei Tiexie capsule) is related to the inhibition of NLRP3 inflammasome activation in vivo and in vitro

Wang, S., Ye, F., Ren, Q., Sun, S., Xia, W., Wang, Z., Guo, H., Li, H., Zhang, S., Lowe, S., et al. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117283 · Cited by 5

Xenobiotic Receptors, a Journey of Rewards

Xie, W. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.122.000857 · Cited by 5

Isoliensinine from Plumula Nelumbinis Attenuates Hepatic Fibrosis in Metabolic Associated Fatty Liver Disease through Regulating Lipid Droplet Metabolism

Wang, S., Tang, L., Hu, M., Zhou, Y., Li, Y., Xia, S., Fu, Q., Shao, J., Xu, X., Wang, F., et al. (2025) · Journal of Future Foods · doi:10.1016/j.jfutfo.2025.07.022 · Cited by 4

Ex vivo removal of pro-fibrotic collagen and rescue of metabolic function in human ovarian fibrosis

del Valle, J. S., van Helden, R. W. J., Moustakas, I., Fu, W. E., Asseler, J. D., Metzemaekers, J., Pilgram, G. S. K., Mummery, C. L., van der Westerlaken, L. A. J., van Mello, N. M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.112020 · Cited by 4

Roles and potential mechanisms of hepatic stellate cells activation mediated by epigenetics through insulin like growth factor 1 and receptor: A review

Chen, S., Gao, J., Chen, J., Huang, Y., Wang, L., Lin, J., Zhao, M., Shen, Y., Zhao, G., & Cheng, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147642 · Cited by 4

Clickable Glutathione‐Based Identification of Cysteine Glutathionylation

Don, N. N. J. M., Kukulage, D. S. K., & Ahn, Y. (2023) · Current Protocols · doi:10.1002/cpz1.907 · Cited by 4

Down‐regulation of miR‐21‐5p by pirfenidone to inhibit fibroblast proliferation in the treatment of acquired tracheal stenosis

Li, W., Huang, P., Wei, J., Tan, S., Liu, G., Qiu, Y., & Wang, G. (2023) · The Clinical Respiratory Journal · doi:10.1111/crj.13727 · Cited by 4

Targeting macrophages in liver fibrosis

González del Barrio, L., Ipsen, D. H., Pfister, D. R., Hancz, D., & Scott, C. L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1835489 · Cited by 3

Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions

Qu, J., Qin, W., Dong, M., Ma, Z., Li, S., Liu, R., Chen, R., Li, C. H., & Li, X. (2026) · MedComm · doi:10.1002/mco2.70750 · Cited by 3

1-benzyl-6-nitro-4-phenyl-4-(methoxycarbonyl)-2(1H)-pyridinone, a novel pirfenidone derivative, alleviate hepatic fibrosis through T cells

Hu, M., Li, J., Zhang, H., Ma, Y., Zhao, B., Xiao, L., Liang, W. Y., Wang, Y., Wang, C., Wu, C., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117907 · Cited by 2

In Situ Assembly of Fluorogenic RNA for Screening Natural Anti‐Liver Fibrosis Products via Dynamic Visualization of COL1A1 mRNA

Bai, R., Zhu, L., Shao, C., Yin, Z., Liu, Q., Gu, Y., & Liu, B. (2025) · Advanced Science · doi:10.1002/advs.202502850 · Cited by 2

Regioselective Alkyne–Aldehyde Coupling under Metal‐Free and Reductant‐Free Conditions

Sun, Z., Huang, X., Zhao, Q., Zhang, Z., Wang, H., Wu, C., & Fu, L. (2026) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.70468 · Cited by 2

Pirfenidone Sensitizes Hepatic Stellate Cells to Ferroptosis by Reprogramming Glutamine and Serine Metabolism for GSH Depletion

Li, J., Wang, L., Li, Y., Wang, J., Buist‐Homan, M., Faber, K. N., & Moshage, H. J. (2026) · Antioxidants · doi:10.3390/antiox15050552 · Cited by 2

Effective therapy of pirfenidone in a patient with idiopathic retroperitoneal fibrosis: report of a case

Zhao, J., & Zhang, Z. (2022) · Clinical Rheumatology · doi:10.1007/s10067-022-06466-8 · Cited by 2

Early Prediction of Radiation-Induced Pulmonary Fibrosis Using Gastrin-Releasing Peptide Receptor-Targeted PET Imaging

Ahn, J. H., Kim, J.-H., Lee, K. C., Park, J. A., Kim, J. Y., Lee, Y., & Lee, Y. J. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00632 · Cited by 2

Exploring the potential of herbal drugs for treating liver fibrosis: a computational screening approach

Ralli, T., & Alhalmi, A. (2025) · Asian Biomedicine · doi:10.2478/abm-2025-0010 · Cited by 1

Carbene–Ketene Formal [3 + 2] Cycloaddition Enabled by Visible-Light-Induced Dual Photolysis of Diazo Compounds

Fang, L., Ren, X., Liu, T., He, F., Zhu, J., Cai, B., Lu, Y., Xuan, J., & Wu, C. (2026) · JACS Au · doi:10.1021/jacsau.6c00336 · Cited by 1

Fluorofenidone Regulates Tumor-Stroma Interaction In Pancreatic Cancer by Inhibiting the Activation of Pancreatic Stellate CellsPreprint

Guo, X., Wang, Z., Li, X., Wang, J., Zhang, N., Buhe, A., & Zhu, B. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4877546

Hydrophilic and lipophilic colchicinoid formulations for therapy of liver fibrosis in murine model

Svirshchevskaya, E. V., Shchegravina, E. S., Gracheva, Y. A., Konovalova, M. V., Акопов, С. Б., Tretiakova, D. S., Rysina, Y. D., Zapevalova, M. V., Schmalz, H., Koroev, D. O., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109397

Ammonia Detoxification Inhibits Liver Metastasis by Reshaping Hepatic Microenvironment

Sun, S., Hu, H., Chen, L., Gao, Y., Sun, P., & Chen, L. (2026) · Advanced Science · doi:10.1002/advs.202521098

A bivalent anti-CTGF aptamer modulates multiple signaling pathways to attenuate liver fibrosis

Wei, J., Yuan, Q., Zhang, X., Chen, Y., Wang, Y., yang, G., Cheng, Y., Li, J., Li, W., Gao, Z., et al. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118845

Étude et modulation des mécanismes contrôlant la résolution de la fibrose du tissu adipeux au cours de l’obésité et de la perte de poids

Rebière, C. (2024) · theses.fr (ABES) · doi:10.70675/68c3d6d8zeed7z4d9ez9fb6z6302a8275981

Glutaredoxin 1 promotes intestinal epithelial cell copper toxicity in inflammatory bowel disease

Zhang, T., Zhang, X., Cai, H., Yu, M., Liu, Q., Song, X., Lin, B., Xu, L., Li, L., Shen, Z., et al. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104164

Hepatic stellate cells targeting lipid nanoparticle mediated RNA delivery for liver fibrosis treatment by autophagy regulation

Yang, L., Wang, J., Wang, C., Xu, Y., Fang, Y., Cai, D., Yu, M., & Zhang, X. (2026) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2026.08.010

Insights in the Immune Molecular Mechanisms of the Trilogy of Liver Cancer

Li, Y., Bin, F., Chunlei, G., & Hui, L. (2026) · Immune discovery. · doi:10.70322/immune.2026.10008

3,4-dehydro-3‑hydroxy-α-lapachone, a novel naphthoquinone, ameliorates hepatic fibrosis by targeting the guanine nucleotide-binding protein G(i) subunit alpha-2/peroxiredoxin 1 signaling axis

Zhang, W., Xu, L.-H., Gao, K., Girimpuhwe, D., Ren, H., Xu, D., Yang, G.-G., Luo, X.-W., Wang, J., & Wu, Q. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158879

Reducing protein oxidation reverses lung fibrosis

Anathy, V., Lahue, K. G., Chapman, D. G., Chia, S. B., Casey, D. T., Aboushousha, R., van der Velden, J. L. J., Elko, E. A., Hoffman, S. M., McMillan, D. H., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0090-y · Cited by 119

The desulfinylation enzyme sulfiredoxin-1 attenuates HSC activation and liver fibrosis by modulating the PTPN12-NLRP3 axis

Kim, J.-W., Tung, H., Ke, M., Xu, P., Cai, X., Xi, Y., Xu, M., Ren, S., Huang, Y., Bhowmik, A., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000001133 · Cited by 12

Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors

Didiášová, M., Singh, R. K., Wilhelm, J., Kwapiszewska, G., Wujak, L. A., Zakrzewicz, D., Schaefer, L., Markart, P., Seeger, W., Lauth, M., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201600892rr · Cited by 82

Potent antioxidant role of Pirfenidone in experimental cirrhosis

Salazar-Montes, A., Ruiz-Corro, L., López-Reyes, A. G., Castrejón-Gómez, E., & Armendáriz‐Borunda, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.110 · Cited by 99

Pirfenidone Sensitizes Hepatic Stellate Cells to Ferroptosis by Reprogramming Glutamine and Serine Metabolism for GSH Depletion

Li, J., Wang, L., Li, Y., Wang, J., Buist‐Homan, M., Faber, K. N., & Moshage, H. J. (2026) · Antioxidants · doi:10.3390/antiox15050552 · Cited by 2